TCOV
USNA icon

Trust Company of Vermont’s Usana Health Sciences USNA Stock Holding History

Trust Company of Vermont’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,100
Closed -$326K – 1041
2019
Q2 		$326K Hold
4,100
– – 0.03% 259
2019
Q1 		$344K Hold
4,100
– – 0.03% 254
2018
Q4 		$483K Hold
4,100
– – 0.05% 215
2018
Q3 		$494K Sell
4,100
-575
-12% -$71.4K 0.04% 224
2018
Q2 		$539K Sell
4,675
-33
-0.7% -$3.61K 0.05% 222
2018
Q1 		$404K Hold
4,708
– – 0.04% 236
2017
Q4 		$349K Hold
4,708
– – 0.03% 256
2017
Q3 		$272K Buy
4,708
+3,900
+483% +$230K 0.03% 287
2017
Q2 		$52K Buy
+808
New +$49.8K 0.01% 494

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trust Company of Vermont's USNA Position: Q3 2019 in Review

Trust Company of Vermont sold out of Usana Health Sciences (USNA) in Q3 2019, closing a stake of 4,100 shares — an estimated $326K sold.

Trust Company of Vermont first reported a position in USNA in Q2 2017 and held it in 9 quarters. The position peaked at $539K in Q2 2018. 169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

  • Trust Company of Vermont reported no remaining Usana Health Sciences position as of Q3 2019 after selling out during the quarter.
  • Trust Company of Vermont sold 4,100 Usana Health Sciences shares in Q3 2019, an estimated $326K.
  • Trust Company of Vermont first reported a position in Usana Health Sciences in Q2 2017 and held it in 9 quarters.
  • Trust Company of Vermont's Usana Health Sciences position peaked at $539K in Q2 2018.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Trust Company of Vermont's 13F filing for Q3 2019, filed 24 Oct 2019.